IFNA1 and autoimmune polyendocrine syndrome type 1: High-titer autoantibodies against type I interferons (IFN-α/ω) are nearly universal in APS-1 and can impair innate antitumor immunity, allowing nascent neoplastic clones to escape immune surveillance.